DAVID CORRY to Eosinophils
This is a "connection" page, showing publications DAVID CORRY has written about Eosinophils.
Connection Strength
0.448
-
Coronavirus vaccine-associated lung immunopathology-what is the significance? Microbes Infect. 2020 10; 22(9):403-404.
Score: 0.161
-
Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis. Immun Inflamm Dis. 2018 06; 6(2):264-275.
Score: 0.137
-
A new mechanism regulating the initiation of allergic airway inflammation. J Allergy Clin Immunol. 2007 Aug; 120(2):334-42.
Score: 0.065
-
Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide. Respir Res. 2021 Oct 10; 22(1):263.
Score: 0.044
-
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med. 1996 Jan 01; 183(1):109-17.
Score: 0.029
-
Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol. 2002 Nov 15; 169(10):5926-33.
Score: 0.012